Company Filing History:
Years Active: 2008-2012
Title: Richard Albang: Innovator in Lipolytic Enzymes
Introduction
Richard Albang is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of lipolytic enzymes. With a total of 3 patents to his name, Albang's work has implications for both industrial processes and medical diagnostics.
Latest Patents
Albang's latest patents focus on a newly identified polynucleotide sequence that encodes a novel lipolytic enzyme. The invention includes the full-length nucleotide sequence of the gene, the cDNA sequence that comprises the full-length coding sequence, and the amino acid sequence of the functional protein. Additionally, the invention outlines methods for utilizing these enzymes in industrial applications and diagnosing fungal infections. It also encompasses cells that have been transformed with the polynucleotide and those in which the lipolytic enzyme has been genetically modified to enhance its activity and expression levels.
Career Highlights
Richard Albang is currently associated with Dsm IP Assets B.V., where he continues to innovate in the field of enzyme technology. His work has been instrumental in advancing the understanding and application of lipases in various sectors.
Collaborations
Albang has collaborated with notable colleagues such as Christian Wagner and Andreas Fritz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Richard Albang's contributions to the field of biotechnology, particularly through his patents on lipolytic enzymes, highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical applications in industry and healthcare.